Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Current advances and unmet needs in Alzheimer's disease trials for individuals with Down syndrome: Navigating new therapeutic frontiers

Alzheimer s & Dementia(2025)10.1002/alz.70258Source: DataRank Database

Current advances and unmet needs in Alzheimer's disease trials for individuals with Down syndrome: Navigating new therapeutic frontiers is a research paper published in Alzheimer s & Dementia (2025). On theSindex it has a DataRank of 0. It has been cited 15 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access15 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 16.66)OA: hybridTopics (23)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Laura Videla ORCID,María Carmona‐Iragui ORCID,Juan Fortea ORCID,Michael S. Rafii ORCID,Isabel Barroeta ORCID

Live enrichment

PubMed:40528298 PMC:PMC12173829 OpenAlex:https://openalex.org/W4411436590

National Institutes of Health

Grant: 1R61AG066543

National Institutes of Health

Grant: R33AG066543

Instituto de Salud Carlos III

Grant: ICI23/00032

Eli Lilly and Company

AC Immune SA

Ionis

AC Immune SA

Eli Lilly and Company

FWCI

16.66

Citation Percentile

1.0%

Citation Trend

2025

2026

hybridLicense: cc-by-nc-nd

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.70258

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.70258

publisherhttps://alz-journals.onlinelibrary.wiley.com/doi/pdf/10.1002/alz.70258

journalhttps://doi.org/10.1002/alz.70258

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40528298

Fields of Study

Down syndrome and intellectual disability researchChronic Disease Management StrategiesDementia and Cognitive Impairment ResearchDown SyndromeHumansAlzheimer DiseaseClinical Trials as Topic

MeSH Terms

Alzheimer DiseaseClinical Trials as TopicDown SyndromeHumans

Keywords

DiseaseMedicineIntensive care medicineClinical trialAlzheimer's diseasePsychologyGerontologyInternal medicineMonoclonal antibodiesBiomarkersDown syndromeClinical Trials

Sustainable Development Goals

SDG 0: Good health and well-being